RecruitingNCT07230652
Official study titleA Randomized, Double-Blind, Placebo-Controlled, Dose- Ascending Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Chinese Adult Healthy Subjects and/or Subjects With Stable Schizophrenia
In BeijingSchizophreniaMedication studyAges 18–60
- Countries
- China
- Sponsor
- Luye Pharma Group Ltd.
RecruitingNCT05995782
About this title
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
Read the official source — NCT05995782Official study titleA Phase 1, Randomized, Double-Blind, Placebo-Controlled, SAD and MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral FB418 in Healthy Adult Subjects and Healthy Elderly Subjects
In SeoulSchizophreniaMedication studyAges 19+
- Countries
- South Korea
- Sponsor
- 1ST Biotherapeutics, Inc.
RecruitingNCT07115329
About this title
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Read the official source — NCT07115329Official study titlePhase 2, Multicenter, Randomized, Double-Blind Evaluation of the Efficacy and Safety of Oral GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Multiple locations, including PhoenixDepressionMedication studyAges 18–64
- Countries
- United States
- Sponsor
- Syndeio Biosciences, Inc
RecruitingNCT07478744
What is this study about?This study evaluates the safety and effectiveness of SYT-510 for people with anxiety.
In LondonAnxietyMedication studyAges 18–55
- Countries
- United Kingdom
- Sponsor
- Synendos Therapeutics AG
RecruitingACTRN12624000449538
Official study titleA Phase 2b double-blind, randomized, low-dose comparator-controlled clinical trial to assess the efficacy and safety of PEX010 in psilocybin-assisted psychotherapy for the treatment of adjustment disorder due to incurable cancer diagnosis
In AustraliaAdjustment disorderInterventional studyAges 18–80
- Countries
- Australia
- Sponsor
- Psyence Australia Pty Ltd
RecruitingNCT07592689
What is this study about?Researchers are comparing DT120, placebo and a simulated comparison procedure to find out how the approaches affect depression symptoms in adults with depression.
Multiple locations, including Little RockDepressionMedication studyAges 18–74
- Countries
- United States
- Sponsor
- Definium Therapeutics US, Inc.
RecruitingACTRN12620000506998
Official study titleA Phase II randomised, double-blind, placebo-controlled trial of S-Adenosyl Methionine (SAMe) in participants with mild cognitive impairment or dementia due to Alzheimer’s disease
In Heidelberg WestMental healthInterventional studyAges 60+
- Countries
- Australia
- Sponsor
- The University of Melbourne
RecruitingACTRN12620000640909
Official study titleA phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health
In AustraliaMental healthInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- University of Melbourne
RecruitingACTRN12618001822279
Official study titleThe Effect on Behaviours with Group-Based Exercise in School-Aged Children with Attention Deficit Hyperactivity Disorder
In AustraliaADHDInterventional studyAges 8–12
- Countries
- Australia
- Sponsor
- Cricket Australia
RecruitingNCT06349915
About this title
A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents
Read the official source — NCT06349915What is this study about?This study assesses suicidal thoughts.
In The BronxSuicidalityBehavioural studyAges 14–18
- Countries
- United States
- Sponsor
- Albert Einstein College of Medicine
RecruitingACTRN12620000266965
Official study titleA pilot gender-sensitised lifestyle intervention for overweight men targeted at physical activity, diet, and mental health
In AustraliaMental healthInterventional studyAges 28–64
- Countries
- Australia
- Sponsor
- University of Technology Sydney
RecruitingACTRN12625000515493
Official study titleA social network theory informed pilot randomised controlled trial addressing body image on social media in adults
In AustraliaMental healthInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Deakin University